Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 09-2019 | 06-2019 | 09-2014 | 06-2014 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 0 | 0 | 0 | 2,230 | 1,360 |
| TOTAL | $N/A | $N/A | $N/A | $2,230 | $1,360 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 1,630 | 1,540 |
| TOTAL | $N/A | $N/A | $N/A | $1,630 | $1,540 |
| Total Assets | $N/A | $N/A | $N/A | $3,860 | $2,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 0 | 40 |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 10,690 | 7,170 |
| Other current liabilities | N/A | N/A | N/A | 100 | 210 |
| TOTAL | $N/A | $N/A | $N/A | $10,790 | $7,420 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 80 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $190 | $110 |
| Total Liabilities | $N/A | $N/A | $N/A | $10,980 | $7,530 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 470 | 490 |
| Other shareholders' equity | 0 | 0 | 0 | -10,380 | 4,180 |
| TOTAL | $N/A | $N/A | $N/A | $148,590 | $168,520 |
| Total Liabilities And Equity | $0 | $0 | $0 | $159,570 | $176,050 |